Fujifilm India has joined hands with Bengaluru-based Sakra World Hospital, in diagnosing the possibility of Covid-19 pneumonia among patients with the help of a new AI-enabled software. This association has been borne out of Fujifilm India’s campaign “Covid-19 Pneumonia Image Analysis Program” which helps in diagnosing chest CT images by offering characteristic image findings of COVID-19 pneumonia across three stages.

As the Covid-19 pneumonia wreaked havoc in India and affected several families in the country, the Covid-AI-enabled software “Covid-19 Pneumonia Image Analysis Program” by Fujifilm India is a software that has strengthened India’s fight towards Covid-19. The technology automatically analyses the chest CT images and displays the results which assists doctors in diagnosing Covid-19 pneumonia and ultimately saving human lives. Additionally, SYNAPSE 3D, a workstation system visualizes and analyzes high-precision 3D images from tomographic images such as CT and MRI by utilizing Fujifilm India’s image recognition technology.

Commenting on the association, Koji Wada, Managing Director, Fujifilm India said, “With our new technology, we aim to reduce the burden on the healthcare workers who have been at the forefront in the fight against Covid.”

Speaking on the occasions, Yuichi Nagano, Managing Director, Sakra World Hospital said, “The Covid-19 pandemic brought along with itself a lot of complications like post-Covid Pneumonia. With this new AI-technology we hope to empower our healthcare workers in fighting such complications.”